Table 3.
Postoperative adverse events.
| Variables | Patients with ST2 <35 (n = 66) | Patients with ST2 ≥35 (n = 14) | p Value |
|---|---|---|---|
| Operative mortality n (%) | 0 | 0 | - |
| Postoperative mortality n (%) | 0 | 2 (14%) | p = 0.02953 |
| Need of inotrophy n (%) | 6 (9%) | 12 (85%) | p < 0.0001 |
| Need of IABP n (%) | 1 (1%) | 3 (21%) | p = 0.0020 |
| MV time, hour | 8 (5–28) | 18 (7–72) | p < 0.0001 |
| Stroke n (%) | 0 | 0 | - |
| Renal failure requiring dialysis n (%) | 2 (3%) | 2 (14%) | p = 0.0811 |
| Re-operation for bleeding n (%) | 3 (4%) | 1 (7%) | p = 0.6873 |
| Respiratory failure n (%) | 0 | 2 (14%) | p = 0.02953 |
| Arrhythmia n (%) | 8 (12%) | 11 (78%) | p < 0.0001 |
| ICU length of stay, days * | 2.5 (1–6) | 4 (2–13) | p = 0.0041 |
| Overall length of stay, days * | 8 (5–17) | 11 (8–23) | p < 0.0001 |
| Postoperative adverse events n (%) | 17 (26) | 14 (100) | p < 0.0001 |
Abbreviations: IABP: intra aortic balloon pump, ICU: intensive care unit, MV: mechanic ventilation. * Comparison was made using Mann–Whitney U test at p < 0.05, and these values were described by median with inter-quartile range (25th and 75th percentile).